Capricor Therapeutics | CAPR - Interest Expense On Debt


Capricor Therapeutics reported 3.05M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Bioline Rx USD 280K 80K Dec/2025
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cipla INR 170.3M 39M Jun/2026
Cytokinetics USD 34.83M 1.5M Jun/2026
Geron USD 7.15M 150K Mar/2026
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 197K 222K Dec/2025
J&J USD 43M 25M Mar/2026
Plus Therapeutics USD 62K 25K Dec/2023
Prothena USD 302.58M 47.32M Jun/2026
PTC Therapeutics USD 3.25B 381.37M Jun/2026
Sarepta Therapeutics USD 21.51M 205K Jun/2026